Perrigo Company plc (PRGO)

33,06 +0,16 (+0,49%) Al cierre: 04:00PM EDT

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin D02 TY74
Ireland
353 1 709 4000
https://www.perrigo.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 9140

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Patrick Lockwood-Taylor	President, CEO & Director	2,37M	N/A	N/A
Mr. Eduardo Guarita Bezerra	Executive VP & CFO	1,2M	N/A	1976
Mr. Ronald C. Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain	1,36M	N/A	1966
Ms. Kyle L. Hanson	Executive VP, General Counsel & Corporate Secretary	943,95k	N/A	1965
Mr. Svend Andersen	Executive VP & President of Consumer Self-Care International	1,11M	N/A	1962
Mr. Shannon Hukill	Senior Director of Technical Operations	N/A	N/A	N/A
Mr. Thomas M. Farrington	Chief Information Officer & Executive VP	N/A	N/A	1957
Ms. Alison Ives	Executive VP & Chief Scientific Officer	N/A	N/A	1981
Mr. Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Mary Reilly-Brest	Director of Global Organizational and Human Resource Development	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Gobierno corporativo

El ISS Governance QualityScore de Perrigo Company plc, a día 1 de mayo de 2024, es 1. Las puntuaciones base son Auditoría: 5; Tablero: 1; Derechos de los accionistas: 1; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.